|
|
 |
ACETYLTRIBUTYL CITRATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
AMMONIA Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NINLARO Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
BENZOIC ACID Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ANHYDROUS DIBASIC CALCIUM PHOSPHATE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ALCOHOL Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
NORFLURANE Drug Excipient Business Development Opportunity Report, 2024 |
$399.00 |
|
$399.00 |
|
|
 |
ORBACTIV Drug Profile, 2024 |
$399.00 |
|
$399.00 |
|
|